Ashish Bansal

184 total papers · 3.4k total citations
84 papers, 999 citations indexed

About

Ashish Bansal is a scholar working on Dermatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Ashish Bansal has authored 84 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Dermatology, 43 papers in Physiology and 40 papers in Immunology and Allergy. Recurrent topics in Ashish Bansal's work include Dermatology and Skin Diseases (61 papers), Asthma and respiratory diseases (43 papers) and Allergic Rhinitis and Sensitization (32 papers). Ashish Bansal is often cited by papers focused on Dermatology and Skin Diseases (61 papers), Asthma and respiratory diseases (43 papers) and Allergic Rhinitis and Sensitization (32 papers). Ashish Bansal collaborates with scholars based in United States, Germany and United Kingdom. Ashish Bansal's co-authors include Eric L. Simpson, Naimish Patel, Amy S. Paller, Ana B. Rossi, Michael J. Cork, Bolanle Akinlade, Neil M.H. Graham, Laurent Eckert, Elaine C. Siegfried and Mohamed Kamal and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Ashish Bansal

71 papers receiving 990 citations

Hit Papers

Dupilumab in patients wit... 2023 2026 2024 2023 2024 2025 25 50 75 100
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
    2023 114 citations Gil Yosipovitch, Nicholas Mollanazar et al. Nature Medicine profile →
  2. Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
    2024 90 citations Surya P. Bhatt, Klaus F. Rabe et al. New England Journal of Medicine profile →
  3. Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
    2025 16 citations Surya P. Bhatt, Klaus F. Rabe et al. The Lancet Respiratory Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ashish Bansal 766 581 439 196 106 84 999
Esther Moreno 306 0.4× 357 0.6× 258 0.6× 168 0.9× 102 1.0× 59 1.0k
Anca Mirela Chiriac 524 0.7× 577 1.0× 254 0.6× 201 1.0× 105 1.0× 54 1.2k
Jerzy Jarząb 300 0.4× 490 0.8× 581 1.3× 68 0.3× 207 2.0× 70 962
Toshio Katsunuma 386 0.5× 452 0.8× 616 1.4× 82 0.4× 274 2.6× 71 1.2k
Gádor Bogas 263 0.3× 599 1.0× 449 1.0× 141 0.7× 96 0.9× 55 942
Oliviero Rossi 258 0.3× 423 0.7× 454 1.0× 188 1.0× 174 1.6× 60 1.1k
Punchama Pacharn 264 0.3× 507 0.9× 169 0.4× 88 0.4× 71 0.7× 81 844
D. Staumont‐Sallé 512 0.7× 334 0.6× 300 0.7× 307 1.6× 92 0.9× 100 1.2k
Elizabeth Laws 219 0.3× 257 0.4× 412 0.9× 269 1.4× 217 2.0× 63 878
Hagen Ott 321 0.4× 420 0.7× 149 0.3× 172 0.9× 60 0.6× 75 1.0k

Countries citing papers authored by Ashish Bansal

Since Specialization
Citations

This map shows the geographic impact of Ashish Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashish Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashish Bansal more than expected).

Fields of papers citing papers by Ashish Bansal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashish Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashish Bansal. The network helps show where Ashish Bansal may publish in the future.

Co-authorship network of co-authors of Ashish Bansal

This figure shows the co-authorship network connecting the top 25 collaborators of Ashish Bansal. A scholar is included among the top collaborators of Ashish Bansal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashish Bansal. Ashish Bansal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nusrat Shafiq Breakdown of academic impact, for papers by Taisuke Masuda Breakdown of academic impact, for papers by Eileen Kraemer Breakdown of academic impact, for papers by P Ténière Breakdown of academic impact, for papers by Michael Owusu Breakdown of academic impact, for papers by Tuan-Anh Nguyen Breakdown of academic impact, for papers by Yu Feng Breakdown of academic impact, for papers by Teresa Gomes
Rankless by CCL
2026